Literature DB >> 22553290

Discrimination between neoplastic and non-neoplastic lesions in cirrhotic liver using contrast-enhanced ultrasound.

H-X Xu1, M-D Lu, L-N Liu, Y-F Zhang, L-H Guo, J-M Xu, C Liu.   

Abstract

OBJECTIVES: To assess the value of contrast-enhanced ultrasound (CEUS) in differentiating hepatocellular carcinoma (HCC) from non-neoplastic lesion in cirrhotic liver in comparison with baseline ultrasound.
METHODS: A total of 147 nodules (diameter ≤5.0 cm) in 133 cirrhotic patients (mean age±standard deviation: 52±13 years, range 20-82 years; gender: 111 males and 22 females) were examined with CEUS. There were 116 HCCs, 26 macroregenerative nodules and 5 high-grade dysplastic nodules. CEUS was performed with a real-time contrast-specific mode and a sulphur hexafluoride-filled microbubble contrast agent.
RESULTS: Hypervascularity was observed in 94.8% (110/116) HCCs, 3.8% (1/26) macroregenerative nodules and 60.0% (3/5) high-grade dysplastic nodules during arterial phase on CEUS. Detection rates of typical vascular pattern (i.e. hypervascularity during arterial phase and subsequent washout) in HCCs with a diameter of ≤2.0 cm, 2.1-3.0 cm and 3.1-5.0 cm were 69.2% (27/39), 97.1% (33/34) and 100.0% (43/43), respectively. CEUS significantly improved the sensitivity [88.8% (103/116) vs 37.1% (43/116), p<0.001], negative predictive value [70.5% (31/44) vs 31.5% (29/92), p<0.001], and accuracy [91.2% (134/147) vs 49.0% (72/147), p<0.001] in differentiating HCCs from non-neoplastic lesions when compared with baseline ultrasound. However, the sensitivity and accuracy of CEUS for HCCs ≤2.0 cm in diameter were significantly lower than those for HCCs of 2.1-3.0 cm and 3.1-5.0 cm in diameter.
CONCLUSIONS: CEUS improves diagnostic performance in differentiating HCCs from non-neoplastic nodules in cirrhotic patients compared with baseline ultrasound. Diagnosis of HCCs ≤2.0 cm diameter by CEUS is still a clinical concern, and thus needs further investigation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22553290      PMCID: PMC3474036          DOI: 10.1259/bjr/19932596

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  46 in total

1.  Management of hepatocellular carcinoma.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2005-11       Impact factor: 17.425

2.  Imaging of peripheral cholangiocarcinoma with low-mechanical index contrast-enhanced sonography and SonoVue: initial experience.

Authors:  Hui-Xiong Xu; Ming-De Lu; Guang-Jian Liu; Xiao-Yan Xie; Zuo-Feng Xu; Yan-Ling Zheng; Jin-Yu Liang
Journal:  J Ultrasound Med       Date:  2006-01       Impact factor: 2.153

3.  Characterization of small focal liver lesions using real-time contrast-enhanced sonography: diagnostic performance analysis in 200 patients.

Authors:  Hui-Xiong Xu; Guang-Jian Liu; Ming-De Lu; Xiao-Yan Xie; Zuo-Feng Xu; Yan-Ling Zheng; Jin-Yu Liang
Journal:  J Ultrasound Med       Date:  2006-03       Impact factor: 2.153

4.  The added diagnostic value of 64-row multidetector CT combined with contrast-enhanced US in the evaluation of hepatocellular nodule vascularity: implications in the diagnosis of malignancy in patients with liver cirrhosis.

Authors:  Emilio Quaia; Valerio Alaimo; Elisa Baratella; Alessandro Medeot; Massimo Midiri; Maria Assunta Cova
Journal:  Eur Radiol       Date:  2008-09-25       Impact factor: 5.315

5.  Percutaneous thermal ablation for recurrent hepatocellular carcinoma after hepatectomy.

Authors:  M-D Lu; X-Y Yin; X-Y Xie; H-X Xu; Z-F Xu; G-J Liu; M Kuang; Y-L Zheng
Journal:  Br J Surg       Date:  2005-11       Impact factor: 6.939

6.  Importance of evaluating all vascular phases on contrast-enhanced sonography in the differentiation of benign from malignant focal liver lesions.

Authors:  Carlos Nicolau; Ramon Vilana; Violeta Catalá; Luis Bianchi; Rosa Gilabert; Angeles García; Concepcio Brú
Journal:  AJR Am J Roentgenol       Date:  2006-01       Impact factor: 3.959

7.  Prognostic factors for long-term outcome after percutaneous thermal ablation for hepatocellular carcinoma: a survival analysis of 137 consecutive patients.

Authors:  H-X Xu; M-D Lu; X-Y Xie; X-Y Yin; M Kuang; J-W Chen; Z-F Xu; G-J Liu
Journal:  Clin Radiol       Date:  2005-09       Impact factor: 2.350

8.  Diagnostic value of hepatocellular nodule vascularity after microbubble injection for characterizing malignancy in patients with cirrhosis.

Authors:  Emilio Quaia; Mirko D'Onofrio; Paolo Cabassa; Francesca Vecchiato; Sabrina Caffarri; Frida Pittiani; Knut M Wittkowski; Maria Assunta Cova
Journal:  AJR Am J Roentgenol       Date:  2007-12       Impact factor: 3.959

9.  Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma.

Authors:  Alejandro Forner; Ramón Vilana; Carmen Ayuso; Lluís Bianchi; Manel Solé; Juan Ramón Ayuso; Loreto Boix; Margarita Sala; María Varela; Josep M Llovet; Concepció Brú; Jordi Bruix
Journal:  Hepatology       Date:  2008-01       Impact factor: 17.425

10.  Enhancement patterns of hepatocellular carcinoma at contrast-enhanced US: comparison with histologic differentiation.

Authors:  Hyun-Jung Jang; Tae Kyoung Kim; Peter N Burns; Stephanie R Wilson
Journal:  Radiology       Date:  2007-09       Impact factor: 11.105

View more
  14 in total

1.  Role of contrast-enhanced ultrasound in follow-up assessment after ablation for hepatocellular carcinoma.

Authors:  Shu-Guang Zheng; Hui-Xiong Xu; Ming-De Lu; Xiao-Yan Xie; Zuo-Feng Xu; Guang-Jian Liu; Lin-Na Liu
Journal:  World J Gastroenterol       Date:  2013-02-14       Impact factor: 5.742

Review 2.  Imaging Diagnosis of Hepatocellular Carcinoma: Recent Advances of Contrast-Enhanced Ultrasonography with SonoVue®.

Authors:  Veronica Salvatore; Alice Gianstefani; Giulia Negrini; Giulia Allegretti; Marzia Galassi; Fabio Piscaglia
Journal:  Liver Cancer       Date:  2015-12-18       Impact factor: 11.740

3.  Differentiation of benign and malignant focal liver lesions: value of virtual touch tissue quantification of acoustic radiation force impulse elastography.

Authors:  Le-Hang Guo; Shu-Jun Wang; Hui-Xiong Xu; Li-Ping Sun; Yi-Feng Zhang; Jun-Mei Xu; Jian Wu; Hui-Jun Fu; Xiao-Hong Xu
Journal:  Med Oncol       Date:  2015-02-19       Impact factor: 3.064

4.  High frame-rate contrast enhanced ultrasound (HIFR-CEUS) in the characterization of small hepatic lesions in cirrhotic patients.

Authors:  F Giangregorio; M Garolfi; E Mosconi; L Ricevuti; M G Debellis; M Mendozza; C Esposito; E Vigotti; D Cadei; D Abruzzese
Journal:  J Ultrasound       Date:  2022-10-13

5.  Hepatocellular carcinoma after ablation: the imaging follow-up scheme.

Authors:  Lin-Na Liu; Hui-Xiong Xu; Yi-Feng Zhang; Jun-Mei Xu
Journal:  World J Gastroenterol       Date:  2013-02-14       Impact factor: 5.742

Review 6.  Management of hepatocellular carcinoma: The role of contrast-enhanced ultrasound.

Authors:  Shu-Guang Zheng; Hui-Xiong Xu; Lin-Na Liu
Journal:  World J Radiol       Date:  2014-01-28

Review 7.  Application of new ultrasound techniques for focal liver lesions.

Authors:  Feiqian Wang; Kazushi Numata; Hiromi Nihonmatsu; Masahiro Okada; Shin Maeda
Journal:  J Med Ultrason (2001)       Date:  2020-01-16       Impact factor: 1.314

8.  Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.

Authors:  Agostino Colli; Tin Nadarevic; Damir Miletic; Vanja Giljaca; Mirella Fraquelli; Davor Štimac; Giovanni Casazza
Journal:  Cochrane Database Syst Rev       Date:  2021-04-15

9.  Time-intensity curve parameters in rectal cancer measured using endorectal ultrasonography with sterile coupling gels filling the rectum: correlations with tumor angiogenesis and clinicopathological features.

Authors:  Yong Wang; Lin Li; Yi-Xiang J Wang; Ning-Yi Cui; Shuang-Mei Zou; Chun-Wu Zhou; Yu-Xin Jiang
Journal:  Biomed Res Int       Date:  2014-05-13       Impact factor: 3.411

10.  Macro- and microcirculation patterns of intrahepatic blood flow changes in patients with hereditary hemorrhagic telangiectasia.

Authors:  Roland C Schelker; Ana P Barreiros; Christina Hart; Wolfgang Herr; Ernst-Michael Jung
Journal:  World J Gastroenterol       Date:  2017-01-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.